Case Study: Stage IV Recurrent Ovarian Cancer Treatment
Dr. Dino Prato and Dr. John Oertle review a stage 4 recurrent metastatic ovarian cancer case. Ovarian cancer is often referred to as the "silent killer" because its early symptoms are vague and easily confused with less serious conditions. This makes early detection challenging and contributes to a higher mortality rate. Survival rates for ovarian cancer are significantly higher when the disease is detected early. Unfortunately, due to the lack of clear symptoms and reliable screening tests, only around 20% of cases are diagnosed early. At Envita, our aim is to expand the range of options available to our patients. We provide access to personalized precision oncology treatments to enhance their chances of effectively fighting their illness and improving their quality of life.
Learn how Envita Medical Centers' advanced precision oncology was deployed to help this patient respond to care.
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
